Sponsor Pipeline

Prime Gene Therapeutics Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
2
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06587685 A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With… Atopic Dermatitis Recruiting
NCT07146126 A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With… Seasonal Allergic Rhinitis Not Yet Recruiting
Phase 2
NCT06837233 A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate… Seasonal Allergic Rhinitis Active, Not Recruiting
Phase 1
NCT07013097 A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033… Lichen Simplex Chronicus Recruiting
NCT07619183 A Study to Evaluate the Multiple Dose Ascending of PG-033 in Healthy Adult Participants. Lichen Simplex Chronicus Not Yet Recruiting
Disease Areas
Get alerts when Prime Gene Therapeutics Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free